In patients, there was no statistically significant correlation between measured DAT availability (with either of the imaging methods) and the duration of symptoms; neither was there any significant correlation with parkinsonism severity according to UPDRS-III, even though there was a trend towards a negative relationship. The gene discussed is SLC6A3; the disease is Parkinson disease.